Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma

Cancer Immunology, Immunotherapy

Volumn 58, Issue 11, 2009, Pages 1821-1832

  Amedei, Amedeo ^a,b   Niccolai, Elena ^a,b   Bella, Chiara Della ^a,b   Cianchi, Fabio ^a   Trallori, Giacomo ^c   Benagiano, Marisa ^a,b   Bencini, Lapo ^c   Bernini, Marco ^c   Farsi, Marco ^c   Moretti, Renato ^c   Del Prete, Gianfranco ^a,b   D'Elios, Mario Milco ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c AOUC   (Italy)

Author keywords

Gastric adenocarcinoma; Gastric cancer antigen associated peptides; Th1 Tc1; Tumor infiltrating lymphocytes

Indexed keywords

HLA A02 ANTIGEN; HLA A24 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT;

AGED; ALLELE; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ADENOCARCINOMA; TH1 CELL; TUMOR ASSOCIATED LEUKOCYTE; ADENOCARCINOMA; APOPTOSIS; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MIDDLE AGED; STOMACH TUMOR; T LYMPHOCYTE;

ADENOCARCINOMA; AGED; ANTIGENS, NEOPLASM; APOPTOSIS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STOMACH NEOPLASMS; T-LYMPHOCYTES;

EID: 70349768386     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0693-8     Document Type: Article

References (51)

1. D Cunningham WH Allum SP Stenning JN Thompson CJ Van de Velde M Nicolson JH Scarffe FJ Lofts SJ Falk TJ Iveson DB Smith RE Langley M Verma S Weeden YJ Chua 2006 MAGIC trial participants perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20
2. MM D'Elios M Manghetti F Almerigogna A Amedei F Costa D Burroni CT Baldari S Romagnani JL Telford G Del Prete 1997 Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer Eur J Immunol 27 1751 1755
3. MM D'Elios A Amedei M Manghetti M Costa CT Baldari AS Quazi JL Telford S Romagnani G Del Prete 1999 Impaired T-cell regulation of B-cell growth in Helicobacter pylori-related gastric low-grade MALT lymphoma Gastroenterology 117 1105 1112
4. MM D'Elios MP Bergman A Azzurri A Amedei M Benagiano JJ De Pont F Cianchi CM Vandenbroucke-Grauls S Romagnani BJ Appelmelk G Del Prete 2001 H(+), K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis Gastroenterology 120 377 386
5. TL Darrow Z Abdel-Wahab MA Quinn-Allen HF Seigler 1996 Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2 Cell Immunol 172 52 59
6. G Del Prete M De Carli M Ricci S Romagnani 1991 Helper activity for immunoglobulin synthesis of T helper type I (Thl) and Th2 human T cell clones: the help of Thl clones is limited by their cytolytic capacity J Exp Med I74 809 813
7. G Del Prete M De Carli C Mastromauro R Biagiotti D Macchia P Falagiani M Ricci S Romagnani 1991 Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production J Clin Invest 83 346 350
8. G Del Prete M De Carli MM D'Elios P Maestrelli M Ricci L Fabbri S Romagnani 1993 Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders Eur J Immunol 23 1445 1449
9. E Elkord RE Hawkins PL Stern 2008 Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy Expert Opin Biol Ther 8 385 395
10. EM El-Omar M Carrington WH Chow KE McColl JH Bream HA Young J Herrera J Lissowska CC Yuan N Rothman G Lanyon M Martin JF Fraumeni Jr CS Rabkin 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402
11. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Ann Oncol 18 581 592
12. Q Ge PD Holler VS Mahajan T Nuygen HN Eisen J Chen 2006 Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms Proc Natl Acad Sci USA 103 1822 1827
13. S Gomi M Nakao F Niiya Y Imamura K Kawano S Nishizaka A Hayashi Y Sobao K Oizumi K Itoh 1999 A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes J Immunol 163 4994 5004
14. RC IA (1994) IARC monograph on the evaluation of carcinogenic risks to humans: Schistosomes, Liver Flukes and Helicobacter pylori, vol 16. IARC, Lyon
15. F Ichihara K Kono A Takahashi H Kawaida H Sugai H Fujii 2003 Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clin Cancer Res 9 4404 4408
16. N Imai N Harashima M Ito Y Miyagi M Harada A Yamada K Itoh 2001 Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases Int J Cancer 94 237 242
17. M Ito S Shichijo N Tsuda M Ochi N Harashima N Saito K Itoh 2001 Molecular basis of T cell-mediated recognition of pancreatic cancer cells Cancer Res 61 2038 2046
18. T Kaper LL Looger H Takanaga M Platten L Steinman WB Frommer 2007 Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle PLoS Biol 5 e257
19. K Kawano S Gomi K Tanaka N Tsuda T Kamura K Itoh A Yamada 2000 Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor infiltrating lymphocytes of lung cancer Cancer Res 60 3550 3558
20. JR Kelley M John 2003 Duggan Gastric cancer epidemiology and risk factors J Clin Epidemiol 56 1 9
21. K Kono A Takahashi H Sugai H Fujii AR Choudhury R Kiessling Y Matsumoto 2002 Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer Clin Cancer Res 8 3394 3400
22. G Kroemer J Pouyssegur 2008 Tumor cell metabolism: cancer's Achilles' heel Cancer Cell 13 472 482
23. T Liakakos DH Roukos 2008 More controversy than ever-challenges and promises towards personalized treatment of gastric cancer Ann Surg Oncol 15 956 960
24. BJ Marchall HM Windsor 2005 The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention Med Clin North Am 89 313 344
25. ST Mayne HA Risch R Dubrow WH Chow MD Gammon TL Vaughan DC Farrow JB Schoenberg JL Stanford H Ahsan AB West H Rotterdam WJ Blot JF Fraumeni Jr 2001 Nutrient intake and risk of subtypes of esophageal and gastric cancer Cancer Epidemiol Biomarkers Prev 10 1055 1062
26. T Minami S Matsueda H Takedatsu M Tanaka M Noguchi H Uemura K Itoh M Harada 2007 Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles Cancer Immunol Immunother 56 689 698
27. T Mine R Gouhara N Hida N Imai K Azuma T Rikimaru K Katagiri M Nishikori A Sukehiro M Nakagawa A Yamada H Aizawa K Shirouzu K Itoh H Yamana 2003 Immunological evaluation of CTL precursor-oriented vaccines for advanced lung cancer patients Cancer Sci 94 548 556
28. T Mine Y Sato M Noguchi T Sasatomi R Gouhara N Tsuda S Tanaka H Shomura K Katagiri T Rikimaru S Shichijo T Kamura T Hashimoto K Shirouzu A Yamada S Todo K Itoh H Yamana 2004 Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses Clin Cancer Res 10 929 937
29. K Mochizuki Y Sato N Tsuda H Shomura M Sakamoto K Matsuura K Ushijima Y Maeda K Katagiri A Yamada S Todo T Kamura M Harada K Itoh 2004 Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen Int J Oncol 25 121 131
30. A Moretta G Pantaleo L Moretta JC Cerottini MC Mingari 1983 Direct demonstration of the clonogenic potential of every human peripheral blood T cell: clonal analysis of HLA-DR expression and cytolytic activity J Exp Med 157 743 751
31. AJ Muller JB DuHadaway PS Donover E Sutanto-Ward GC Prendergast 2005 Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy Nat Med 11 312 319
32. S Nagaraj DI Gabrilovich 2008 Tumor escape mechanism governed by myeloid-derived suppressor cells Cancer Res 68 2561 2563
33. M Naito Y Komohara Y Ishihara M Noguchi Y Yamashita T Shirakusa A Yamada K Itoh M Harada 2007 Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles Br J Cancer 97 1648 1654
34. M Nakao S Shichijo T Imaizumi Y Inoue K Matsunaga A Yamada M Kikuchi N Tsuda K Ohta S Takamori H Yamana H Fujita K Itoh 2000 Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL J Immunol 164 2565 2574
35. M Naumann JE Crabtree 2004 Helicobacter pylori-induced epithelial cell signaling in gastric carcinogenesis Trends Microbiol 12 29 36
36. F Niiya S Nishizaka K Matsunaga K Koufuji M Mori H Katai H Yamana K Itoh 2000 Expression of SART3 tumor-rejection antigen in gastric cancers Jpn J Cancer Res 91 337 342
37. MI Nishimura D Avichezer MC Custer CS Lee C Chen MR Parkhurst RA Diamond PF Robbins DJ Schwartzentruber SA Rosenberg 1999 MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte Cancer Res 59 6230 6238
38. S Nishizaka S Gomi K Harada K Oizumi K Itoh S Shichijo 2000 A new tumor- rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma Cancer Res 60 4830 4837
39. Ocean AJ, Schnoll-Sussman F, Keresztes R, Chen X, Holloway S, Matthews N, Christos P, Mazumdar M, Wright J, Wadler S (2006) Phase II study of PS-341 (bortezomib) with or without irinotecan in patients (pts) with advanced gastric adenocarcinomas (AGA). J Clin Oncol (20 June Supplement):14040
40. M Ohyauchi A Imatani M Yonechi N Asano A Miura K Iijima T Koike H Sekine S Ohara T Shimosegawa 2005 The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population Gut 54 330 335
41. RM Peek MJ Blaser 2002 Helicobacter pylori and gastrointestinal adenocarcinomas Nat Rev Cancer 2 28 37
42. A Rocco G Nardone 2007 Diet, H pylori infection and gastric cancer: evidence and controversies World J Gastroenterol 13 2901 2912
43. DH Roukos AM Kappas 2005 Perspectives in the treatment of gastric cancer Nat Clin Pract Oncol 2 98 107
44. Y Sato H Shomura Y Maeda T Mine Y Une Y Akasaka M Kondo S Takahashi T Shinohara K Katagiri M Sato S Okada K Matsui A Yamada H Yamana K Itoh S Todo 2003 Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide Cancer Sci 94 802 808
45. Y Sato T Fujiwara T Mine H Shomura S Homma Y Maeda N Tokunaga Y Ikeda Y Ishihara A Yamada N Tanaka K Itoh M Harada S Todo 2007 Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients Cancer Sci 98 1113 1119
46. MA Shah RK Ramanathan DH Ilson A Levnor D D'Adamo E O'Reilly A Tse R Trocola L Schwartz M Capanu GK Schwartz DP Kelsen 2006 Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma J Clin Oncol 24 5201 5206
47. S Shichijo M Nakao Y Imai H Takasu M Kawamoto F Niiya D Yang Y Toh H Yamana K Itoh 1998 A gene encoding antigenic peptides of human squamouscell carcinoma recognized by cytotoxic T lymphocytes J Exp Med 187 277 288
48. R Somasundaram P Robbins D Moonka E Loh F Marincola A Patel D Guerry D Herlyn 2000 CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells Int J Cancer 85 253 259
49. U Vanhoefer M Tewes F Rojo O Dirsch N Schleucher O Rosen J Tillner A Kovar AH Braun T Trarbach S Seeber A Harstrick J Baselga 2004 Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor J Clin Oncol 22 175 184
50. M Vergelli B Hemmer PA Muraro L Tranquilli WE Biddison A Sarin HF McFarland R Martin 1997 Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis J Immunol 158 2756 2761
51. D Yang M Nakao S Shichijo T Sasatomi H Takasu H Matsumoto K Mori A Hayashi H Yamana K Shirouzu K Itoh 1999 Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLAA24-restricted cytotoxic T lymphocytes in cancer patients Cancer Res 59 4056 4063